Latest News in the pharma Industry

Market News

FDA approves removal of boxed warning regarding serious neuropsychiatric events from Chantix labeling

FDA approves removal of boxed warning regarding serious neuropsychiatric events from Chantix labeling

19 Dec 2016

Labeling revisions also include updates to corresponding warning and addition of clinical data on superior efficacy of Chantix compared with bupropion or nicotine patch.

Read more 
Sanner IDP-Process – individual packaging in six steps

Sanner IDP-Process – individual packaging in six steps

19 Dec 2016

Pharmapack 2017: focus on tailor-made packaging. solutions

Read more 
Boehringer Ingelheim and Lilly welcome new recommendation for Jardiance tablets in updated ADA's 2017 Standards

Boehringer Ingelheim and Lilly welcome new recommendation for Jardiance tablets in updated ADA's 2017 Standards

18 Dec 2016

Guidelines include new recommendation to consider the use of Jardiance in people with type 2 diabetes and established cardiovascular disease to reduce the risk of cardiovascular death.

Read more 
Mylan launches the first generic for EpiPen Auto-Injector as an authorized generic

Mylan launches the first generic for EpiPen Auto-Injector as an authorized generic

16 Dec 2016

Authorized generic offered at more than 50% below wholesale acquisition cost of EpiPen auto-injector.

Read more 
Merck's Idenix Pharmaceuticals awarded $2.54 billion for infringement of a hepatitis C drug patent

Merck's Idenix Pharmaceuticals awarded $2.54 billion for infringement of a hepatitis C drug patent

16 Dec 2016

In its decision, the jury also concluded that Gilead “willfully” infringed upon the patent.

Read more 
bluebird bio and apceth Biopharma establish commercial drug product manufacturing agreement

bluebird bio and apceth Biopharma establish commercial drug product manufacturing agreement

15 Dec 2016

apceth Biopharma will perform clinical manufacturing, process validation activities and commercial manufacturing for LentiGlobin and Lenti-D drug product.

Read more 
Lonza to acquire Capsugel

Lonza to acquire Capsugel

15 Dec 2016

Acquisition will make Lonza a fully integrated solutions provider in oral delivery technologies and active ingredients to the consumer healthcare and nutrition markets.

Read more 
Catalent Biologics to collaborate with PATH Malaria Vaccine Initiative

Catalent Biologics to collaborate with PATH Malaria Vaccine Initiative

15 Dec 2016

Catalent Biologics will employ its proprietary GPEx cell line technology and ambr workstation to develop, optimize the process for expression, and manufacture antibodies for further investigation by MVI and its partners.

Read more 
Expansion of Sartorius Stedim Cellca

Expansion of Sartorius Stedim Cellca

14 Dec 2016

Laboratory and office facility to be constructed on the site by 2019.

Read more 
Cancer immunotherapies space to witness extraordinary growth

Cancer immunotherapies space to witness extraordinary growth

14 Dec 2016

Several late-stage pipeline drugs are expected to achieve blockbuster status by the end of 2022,

Read more 
Recipharm bolsters development business with new appointments in the US and Europe

Recipharm bolsters development business with new appointments in the US and Europe

14 Dec 2016

CDMO appoints Anders Högdin and Aaron Small to lead the growth of its pharmaceutical development services business in the US and Europe.

Read more 
Acousia Therapeutics receives EUR 2.5 M to develop innovative therapy to treat and prevent sensorineural hearing loss

Acousia Therapeutics receives EUR 2.5 M to develop innovative therapy to treat and prevent sensorineural hearing loss

14 Dec 2016

New shareholder, Axxamof Milan, Italy, will transfer certain therapeutic assets to the R&D programs of Acousia.

Read more